Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Stomach Neoplasms 4 Colorectal Neoplasms 3 Colonic Neoplasms 3 Peritoneal Neoplasms 2 Rectal Neoplasms 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Neoplastic Cells, Circulating 1 Myofibroma 1 Melanoma 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Locally Advanced Pancreatic Adenocarcinoma 1 Liver Neoplasms 1 Genital Neoplasms, Female 1 Gastrointestinal Stromal Tumors 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Clinical Stage I Gastric Cancer AJCC v8 1 Cholangiocarcinoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Merkel Cell 1 Breast Neoplasms 1 Appendiceal Neoplasms 1

Interventions

relugolix 2 carbetocin 1 Uterine Myomectomy 1 Observation 1 Misoprostol 1 Methylergonovine 1 Laparoscopy 1 Ergonovine 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Myofibroma × Laparoscopy × 1 year × Clear all

NCT06067971 2025-09-12

ENDORA2

University Hospital, Clermont-Ferrand

Phase NA Completed

Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡